Balaxi Pharmaceuticals Ltd. - Research Center
Group () BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 108.14 | 101.29 | 86.87 | 45.63 | 13.60 |
| Expenses | |||||
| Material consumed | 82.10 | 76.92 | 63.33 | 33.58 | 10.24 |
| Manufacturing expenses | 0.04 | - | - | - | - |
| Personnel expenses | 4.04 | 2.90 | 1.95 | 1.76 | 0.90 |
| Selling expenses | 0.21 | 0.40 | 0.07 | 0.10 | 0.02 |
| Adminstrative expenses | 4.93 | 3.81 | 2.63 | 3.73 | 0.81 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 91.32 | 84.03 | 67.98 | 39.17 | 11.96 |
| Operating profit | 16.82 | 17.26 | 18.89 | 6.46 | 1.63 |
| Other recurring income | 6.60 | 2.75 | 1.81 | 2.81 | 0.81 |
| Adjusted PBDIT | 23.42 | 20.01 | 20.70 | 9.27 | 2.44 |
| Financial expenses | 0.46 | 0.06 | 0.01 | - | - |
| Depreciation | 0.52 | 0.25 | 0.09 | 0.01 | - |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 22.45 | 19.70 | 20.60 | 9.27 | 2.44 |
| Tax charges | 6.23 | 5.03 | 5.46 | 2.77 | 0.47 |
| Adjusted PAT | 16.22 | 14.67 | 15.13 | 6.50 | 1.97 |
| Non recurring items | - | - | - | - | - |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 16.22 | 14.67 | 15.13 | 6.50 | 1.97 |
| Earnigs before appropriation | 52.84 | 36.61 | 21.95 | 6.81 | 0.32 |
| Equity dividend | 0.50 | - | - | - | - |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | - |
| Retained earnings | 52.34 | 36.61 | 21.95 | 6.81 | 0.32 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis